Papers
1
Total Citations
1
H-Index
1
About
Dr. Sujung Oh is a pioneering gynecologic oncologist whose research focuses on fertility-sparing surgical treatments for cervical cancer, particularly in early-stage disease. Her most cited work, a 2022 case study, explores neoadjuvant chemotherapy with a cisplatin-VP16 regimen followed by robotic radical trachelectomy for patients with FIGO 2018 stage IB2 cervical cancer. This contribution is significant because it addresses the critical challenge of balancing oncologic safety with reproductive preservation, especially as delayed childbearing becomes more common. By demonstrating the feasibility of combining chemotherapy with minimally invasive robotic surgery, Dr. Oh offers a potential alternative to radical hysterectomy, which traditionally sacrifices fertility. While her citation count is currently modest, the clinical relevance of her work is high, targeting a pressing need in women’s oncology. Her research underscores the importance of individualized treatment strategies that prioritize both cancer control and quality of life. Dr. Oh’s dedication to advancing surgical techniques and fertility preservation marks her as a rising voice in gynecologic oncology, with implications for improving outcomes for young women facing cervical cancer.
Research Focus
Key Achievements
Top Papers
- 1